Search Results - "BRANCH, R. A"

Refine Results
  1. 1

    Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity by Zgheib, N. K., Frye, R. F., Tracy, T. S., Romkes, M., Branch, R. A.

    Published in British journal of clinical pharmacology (01-04-2007)
    “…Aims We investigated flurbiprofen pharmacokinetics in 12 volunteers to develop a phenotypic trait measure that correlates with the fractional clearance to…”
    Get full text
    Journal Article
  2. 2

    River Plume Liftoff Dynamics and Surface Expressions by Branch, R. A., Horner‐Devine, A. R., Kumar, N., Poggioli, A. R.

    Published in Water resources research (01-07-2020)
    “…The water surface expression of liftoff and its dependence on discharge are examined using numerical simulations with the Regional Ocean Modeling System…”
    Get full text
    Journal Article
  3. 3

    Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes by Frye, Reginald F., Matzke, Gary R., Adedoyin, Adedayo, Porter, James A., Branch, Robert A.

    Published in Clinical pharmacology and therapeutics (01-10-1997)
    “…Objectives To determine whether the probe drugs caffeine, chlorzoxazone, dapsone, debrisoquin (INN, debrisoquine), and mephenytoin can be simultaneously…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Development of dapsone toxicity in patients with inflammatory dermatoses: Activity of acetylation and hydroxylation of dapsone as risk factors by Bluhm, Ranata E., Adedoyin, Adedayo, McCarver, D. G., Branch, Robert A.

    Published in Clinical pharmacology and therapeutics (01-06-1999)
    “…Background Alternative independent routes of dapsone metabolism include N‐hydroxylation to the hydroxylamine, a potentially toxic metabolite, by cytochrome…”
    Get full text
    Journal Article
  6. 6

    Effectiveness of antipsychotic therapy in a naturalistic setting : A comparison between risperidone, perphenazine, and haloperidol by COLEY, K. C, CARTER, C. S, DAPOS, S. V, MAXWELL, R, WILSON, J. W, BRANCH, R. A

    Published in The journal of clinical psychiatry (01-12-1999)
    “…Therapeutic ineffectiveness and noncompliance with antipsychotic agents are major contributors to rehospitalization in patients with psychotic disorders. It is…”
    Get full text
    Journal Article
  7. 7

    Estrogen and Tamoxifen Metabolites Protect Smooth Muscle Cell Membrane Phospholipids Against Peroxidation and Inhibit Cell Growth by Dubey, Raghvendra K, Tyurina, Yulia Y, Tyurin, Vladimir A, Gillespie, Delbert G, Branch, Robert A, Jackson, Edwin K, Kagan, Valerian E

    Published in Circulation research (05-02-1999)
    “…The goal of this study was to test the hypothesis that antioxidant estrogens, by a mechanism independent of the estrogen receptor, protect phospholipids…”
    Get full text
    Journal Article
  8. 8

    Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects by Suri, A, Reddy, S, Gonzales, C, Knadler, M P, Branch, R A, Skinner, M H

    “…To compare the pharmacokinetics of single-dose duloxetine in cirrhotic and healthy subjects. An open-label inpatient study compared duloxetine pharmacokinetics…”
    Get full text
    Journal Article
  9. 9

    Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations by Nakamura, K, Goto, F, Ray, W A, McAllister, C B, Jacqz, E, Wilkinson, G R, Branch, R A

    Published in Clinical pharmacology and therapeutics (01-10-1985)
    “…Interethnic differences in debrisoquin and mephenytoin hydroxylation have been compared between normal white (n = 183) and Japanese (n = 100) subjects with the…”
    Get more information
    Journal Article
  10. 10

    Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6 by Adedoyin, Adedayo, Arns, Patricia A., Richards, W.O., Wilkinson, Grant R., Branch, Robert A.

    Published in Clinical pharmacology and therapeutics (01-07-1998)
    “…Background and Objectives Drug metabolism is influenced by liver disease because of the central role that the liver plays in metabolic activities in the body…”
    Get full text
    Journal Article
  11. 11

    Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail by Adedoyin, Adedayo, Frye, Reginald F., Mauro, Kelly, Branch, Robert A.

    Published in British journal of clinical pharmacology (01-09-1998)
    “…Aims  The aim of this study was to investigate whether chloroquine can inhibit drug metabolism in humans, if such inhibition is general or selective for…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4 by Fleming, C M, Branch, R A, Wilkinson, G R, Guengerich, F P

    Published in Molecular pharmacology (01-05-1992)
    “…One of the major routes of elimination of dapsone (4,4'-diaminodiphenylsulfone) is by N-oxidation, to produce a hydroxylamine metabolite. The specific form of…”
    Get more information
    Journal Article
  13. 13

    Drugs in liver disease by Branch, Robert A.

    Published in Clinical pharmacology and therapeutics (01-10-1998)
    “…Clinical Pharmacology & Therapeutics (1998) 64, 462–465; doi:…”
    Get full text
    Journal Article
  14. 14

    A Pharmacokinetic Study of Amphotericin B Lipid Complex Injection (Abelcet) in Patients with Definite or Probable Systemic Fungal Infections by ADEDOYIN, Adedayo, SWENSON, Christine E, BOLCSAK, Lois E, HELLMANN, Andrzej, RADOWSKA, Danuta, HORWITH, Gary, JANOFF, Andrew S, BRANCH, Robert A

    Published in Antimicrobial Agents and Chemotherapy (01-10-2000)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism by Wedlund, P J, Aslanian, W S, McAllister, C B, Wilkinson, G R, Branch, R A

    Published in Clinical pharmacology and therapeutics (01-12-1984)
    “…The ability of normal subjects to hydroxylate mephenytoin (100 mg) or debrisoquine (10 mg) after oral dosing was investigated in 156 unrelated Caucasians…”
    Get more information
    Journal Article
  17. 17

    Effect of salt supplementation on amphotericin B nephrotoxicity by Llanos, Alejandro, Cieza, Javier, Bernardo, Jose, Echevarria, Juan, Biaggioni, Italo, Sabra, Ramzi, Branch, Robert A.

    Published in Kidney international (01-08-1991)
    “…Effect of salt supplementation on amphotericin B nephrotoxicity. It has been suggested that salt loading protects against amphotericin B-in-duced…”
    Get full text
    Journal Article
  18. 18

    Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population by May, D G, Porter, J, Wilkinson, G R, Branch, R A

    Published in Clinical pharmacology and therapeutics (01-05-1994)
    “…Phenotypic trait values in 166 healthy white subjects (age range, 18 to 88 years) were determined for dapsone N-hydroxylation, dapsone N-acetylation,…”
    Get more information
    Journal Article
  19. 19

    Amphotericin B protects cis-parinaric acid against peroxyl radical-induced oxidation: amphotericin B as an antioxidant by OSAKA, K, RITOV, V. B, BERNARDO, J. F, BRANCH, R. A, KAGAN, V. E

    Published in Antimicrobial Agents and Chemotherapy (01-04-1997)
    “…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  20. 20

    Changing physician prescribing behavior: the community-acquired pneumonia intervention trial by Coley, KC, Skledar, SJ, Fine, MJ, Yealy, DM, Gleason, PP, Ryan, ML, Kapoor, W, Branch, RA

    Published in American journal of health-system pharmacy (15-08-2000)
    “…The Notes section welcomes the following types of contributions: (1) practical innovations or solutions to everyday practice problems, (2) substantial updates…”
    Get full text
    Journal Article